Senseonics Holdings (SENS) Cash from Investing Activities Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | 171.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.06% |
| Dec 31, 2025 | -52.50% |
| Sep 30, 2025 | 468.66% |
| Jun 30, 2025 | -59.96% |
| Mar 31, 2025 | -199.79% |
| Dec 31, 2024 | 31.69% |
| Sep 30, 2024 | -87.98% |
| Jun 30, 2024 | -967.93% |
| Mar 31, 2024 | -15.25% |
| Dec 31, 2023 | 392.45% |
| Sep 30, 2023 | 222.46% |
| Jun 30, 2023 | -118.16% |
| Mar 31, 2023 | 52.28% |
| Dec 31, 2022 | 17.71% |
| Sep 30, 2022 | -133.34% |
| Jun 30, 2022 | 115.44% |
| Mar 31, 2022 | 178,881.82% |
| Sep 30, 2021 | -322,400.00% |
| Jun 30, 2021 | -186,191.03% |
| Mar 31, 2021 | 89.00% |
| Sep 30, 2020 | 98.60% |
| Jun 30, 2020 | 68.29% |
| Mar 31, 2020 | 79.59% |
| Dec 31, 2019 | -101.65% |
| Sep 30, 2019 | -114.40% |
| Jun 30, 2019 | 93.77% |
| Mar 31, 2019 | -103.03% |
| Dec 31, 2018 | 115.85% |
| Sep 30, 2018 | 109.96% |
| Jun 30, 2018 | 35.70% |
| Mar 31, 2018 | 207.56% |
| Dec 31, 2017 | 41.98% |
| Sep 30, 2017 | -61.74% |
| Jun 30, 2017 | -1,789.23% |
| Mar 31, 2017 | 14,324.32% |
| Sep 30, 2016 | -7,433.33% |
| Jun 30, 2016 | -432.79% |